InMed Pharmaceuticals Investor Relations Material
Latest events
Status Update
InMed Pharmaceuticals
Q3 2025
11 May, 2025
Q2 2025
13 Feb, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from InMed Pharmaceuticals Inc
Access all reports
InMed Pharmaceuticals Inc is a Canadian biotechnology company specializing in the research and development of rare cannabinoids. The company focuses on creating pharmaceutical and consumer health products derived from cannabinoid compounds using biosynthesis and chemical synthesis technologies. Its operations span proprietary drug development and manufacturing services. InMed Pharmaceuticals Inc is headquartered in Vancouver, Canada, and its shares are listed on the NASDAQ.
Key slides for InMed Pharmaceuticals Inc
Status Update
InMed Pharmaceuticals Inc
Status Update
InMed Pharmaceuticals Inc
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
INM
Country
🇺🇸 United States